NOVT — Novanta Inc.
Technology · ETF XLK · as of 2026-09-22
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
Price & today
| Stock today | +7.34% |
| Sector ETF today | +0.73% |
| Residual (stock-specific) | +6.61% |
Sector correlation
| 20-day correlation with XLK | 0.49 |
| 60-day correlation with XLK | 0.53 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $139.29 |
| 20 EMA | $142.18 |
| 50 EMA | $146.34 |
| EMA stack | BEARISH |
| RSI(14) | 50.5 |
| 52-week high distance | -18.26% |
| 52-week low distance | +46.71% |
Signals
| Market F&G | 45.1 |
| Bull% | 12.9% |
| OVTLYR status | SELL (20d) |
| Sector rank | #302 |
| Next earnings | 2026-11-02 (TNS, 40d) |
MarketSmith metrics - our compute
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
Company data - context read, not entry inputs
Quarterly EPS - earnings acceleration
A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Nov-24 | 0.85 | +0% | 244.4 | +10% |
| Feb-25 | 0.76 | +21% | 238.1 | +13% |
| May-25 | 0.74 | +0% | 233.4 | +1% |
| Aug-25 | 0.76 | +4% | 241.0 | +2% |
| Nov-25 | 0.87 | +2% | 247.8 | +1% |
| Feb-26 | 0.91 | +20% | 258.3 | +9% |
| May-26 | 0.81 | +9% | 257.7 | +10% |
| Aug-26 | 0.89 | +17% | 265.8 | +10% |
eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).Recent news - our DB (Finnhub + OVTLYR)
- Sep 08 + The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT Zacks Investment Research
- Aug 18 + Recent Price Trend in Novanta (NOVT) is Your Friend, Here's Why Zacks Investment Research
- Aug 14 · 5 Revealing Analyst Questions From Novanta’s Q2 Earnings Call Yahoo
- Aug 13 · $1000 Invested In Novanta 15 Years Ago Would Be Worth This Much Today Benzinga
- Aug 13 · Novanta (NOVT) Q2 2026 Earnings Call Transcript Yahoo
- Aug 12 + Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice Zacks Investment Research
- Aug 12 · Are You Looking for a Top Momentum Pick? Why Novanta (NOVT) is a Great Choice Yahoo
- Aug 10 · NOVT Q2 Deep Dive: Acquisition and Manufacturing Moves Drive Outlook Higher Yahoo